We've helped numerous companies go from startup to succesfully listed on major exchanges. Clients include or have included, Bioenvision (Nasdaq:BIVN), CryoPort (OTCBB:CYRX), EMTA Holdings (OTCBB:EMHD), Biophan Technologies (OTCBB:BIPH), and Netsmart Technologies (Nasdaq:NTST). Over the course of our work for our clients, they have achieved significant share price increases from the time of our being contracted. Clients have raised approximately $100MM in the last three years.
Specialties
Carpe DM specializes in investor relation targeted towards institutional investors, business development for technology and biotech/healthcare companies, mergers & acquisition advice and sourcing, and capital raising.
